Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/31680| Title: | Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design. | Austin Authors: | Olaiya, Muideen T;Andrew, Nadine E;Dalli, Lachlan L;Ung, David;Kim, Joosup;Cadilhac, Dominique A;Wood, Peter;May, Janet;Clissold, Ben;Kilkenny, Monique F | Affiliation: | Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia. The Florey Institute of Neuroscience and Mental Health Division of Medicine, Queensland Health, Brisbane, Queensland, Australia. Latrobe Regional Hospital, Traralgon West, Victoria, Australia. |
Issue Date: | 2022 | Date: | 2022 | Publication information: | Neuroepidemiology 2022 | Abstract: | Observational studies are increasingly being used to provide evidence on the real-world effectiveness of medications for preventing vascular diseases, such as stroke. We investigated whether the real-world effectiveness of treatment with lipid-lowering medications after ischemic stroke is affected by prevalent-user bias. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/31680 | DOI: | 10.1159/000526071 | ORCID: | Journal: | Neuroepidemiology | Start page: | 365 | End page: | 372 | PubMed URL: | 35863320 | ISSN: | 1423-0208 | Type: | Journal Article | Subjects: | Adherence Bias Mortality Outcomes Secondary prevention Stroke Australia/epidemiology Stroke/drug therapy Stroke/epidemiology Lipids/therapeutic use |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.